Dupixent & CTCL Lawsuit News & Updates
Dupixent-related CTCL claims still scatter across jurisdictions because no nationwide MDL exists yet. Follow emerging complaint themes—lymphoma latency, dermatology monitoring gaps, and label history—without mirroring endocrine-drug hubs.
Last updated: May 13, 2026
Dupixent & CTCL Litigation at a Glance
No MDL yet
—
Filing stage
Check back for updates
Latest Dupixent & CTCL Lawsuit Update
Filers contend Dupixent’s immunomodulation could accelerate or unmask CTCL in patients already prone to cutaneous lymphomas. Because dockets are fragmented, watch for the first federal tag-along orders or state-court science days to set the tone.
Current Dupixent & Cutaneous T-Cell Lymphoma Lawsuit News
- •Lawsuits allege Dupixent (dupilumab) may be associated with an increased risk of cutaneous T-cell lymphoma (CTCL) in some patients.
- •Dupixent is approved for eczema, asthma, chronic rhinosinusitis, and other conditions; plaintiffs claim inadequate warning of lymphoma risk.
- •Litigation is in early stages; no federal MDL has been established yet.
- •If you used Dupixent and were diagnosed with CTCL or another T-cell lymphoma, a free case review can help determine your options.
Litigation Status
Dupixent and cutaneous T-cell lymphoma litigation is in early stages. No federal multidistrict litigation (MDL) has been established yet. Individual cases may be filed in state or federal court. As more cases are filed, consolidation may be considered. Check this hub for updates on MDL status, key dates, and settlement developments.
Think You May Qualify?
If you used Dupixent and were diagnosed with cutaneous T-cell lymphoma (CTCL) or another T-cell lymphoma, you may be eligible for a free case review. Get the full picture on eligibility and how to get connected with a law firm.
Dupixent & CTCL Lawsuit – Free Case ReviewFrequently Asked Questions
Ready to See If You Qualify?
Free, confidential case review. No obligation. We may connect you with an independent law firm if appropriate.
Start Free Case ReviewDisclaimer
This Dupixent lawsuit news page is for informational purposes only and does not constitute legal advice. Top Tier Legal LLC is not a law firm. Litigation status may change. For the most current Dupixent lawsuit update and to see if you qualify for a free case review, visit our Dupixent & CTCL lawsuit page or contact us.